Literature DB >> 7680356

Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis.

Z M Lei1, C V Rao, S R Lincoln, D M Ackermann.   

Abstract

Adenomyosis is a benign disease in women in which myometrium is invaded by endometrial glands and stroma. Our laboratory recently demonstrated that normal human endometrial glands and stroma express the hCG/LH receptor gene. This prompted us to investigate whether invading glands and stroma in adenomyosis also express this receptor gene. Fifteen hysterectomy specimens with confirmed histological diagnosis of adenomyosis were examined for hCG/LH receptors by in situ hybridization and immunocytochemistry. The results showed that invading glands contained more receptor mRNA and receptor protein than noninvading glands in the same endometrium. However, the degree of difference between invading and noninvading glands varied among the patients. The higher receptor expression in invading glands is specific because the invading and noninvading stroma showed similar receptor expression, invading and noninvading glands showed similar expression of cadherin, a cell adhesion receptor, and ectopic and eutopic endometrial glands from endometriosis showed similar hCG/LH receptor expression. In summary, the present results demonstrate that invading endometrial glands in adenomyosis selectively express more hCG/LH receptor mRNA and immunoreactive receptor protein than noninvading glands. Whether this increased receptor expression is the cause or a consequence of myometrial invasion of glands in unknown.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680356     DOI: 10.1210/jcem.76.3.7680356

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  The LH/hCG Axis in Endometrial Cancer: A New Target in the Treatment of Recurrent or Metastatic Disease.

Authors:  A Arcangeli; I Noci; A Fortunato; G F Scarselli
Journal:  Obstet Gynecol Int       Date:  2010-07-15

3.  Beta-hCG/LH receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?

Authors:  Gernot Hudelist; Pia Wuelfing; Klaus Czerwenka; Martin Knöfler; Sandra Haider; Anneliese Fink-Retter; Daphne Gschwantler-Kaulich; Georg Pfeiler; Ernst Kubista; Christian F Singer
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-29       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.